<!DOCTYPE html>
<html>
    <head>
        <title></title>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">

        <link href="../css/bootstrap.min.css" rel="stylesheet">
        <link href="../css/docs.min.css" rel="stylesheet">
        <link href="../css/patch.css" rel="stylesheet">
        <link href="../css/main.css" type="text/css" rel="stylesheet">

        <script src="../js/jquery.min.js"></script>
        <script src="../js/bootstrap.min.js"></script>
        <script src="../js/docs.min.js"></script>
        <script src="../js/ie10-viewport-bug-workaround.js"></script>
        <script src="../js/ie-emulation-modes-warning.js"></script>
    </head>
<body>
	<script src="../js/header_judging.js"></script>

    <div class="container">
        <div class="row">
            <div class="col-md-12">
                <div class="bs-docs-section">
                    <div class="h1"">We have achieved following experiment results as our PROOF OF CONCEPT.</div>
                    <div class="p">(A) We have constructed a signal pathway (in principle) in which bacteria detects Nitric Oxide (NO) released in the inflammation sites in IBD patients, expresses therapeutic molecule - Epidermal Growth Factors (EGF) and releases them back to inflammation sites to relieve IBD symptoms. This is illustrated in Figure 1. </div>
                    <div class="row">
                        <div class="col-md-12">
                            <img class="img-responsive" style="margin:30px auto;" src="../img/proof1.png">
                        </div>
                        <div style="font-size:16px;text-align:center;width:80%;display:block;margin:10%;margin-bottom:1em;">
                            <b>Figure 1.</b>
                        </div>
                    </div>
                    <div class="p">Specifically, 1) we mimicked NO release at pathological concentration by SNP (see <a href="../Project#NO_Sensor">NO release</a>).</div>
                    <div class="p">2) we successfully used NO (released by SNP) to induce expression of a demo protein (GFP), under control of a NO sensitive promoter (pNorV) (see <a href="../Project#NO_Sensor">NO sensing</a>). The demo protein can be easily replaced by the therapeutic molecule – EGF.</div>
                    <div class="p">3) we successfully demonstrated that our bacterial expressed EGF could relieve the symptoms in IBD mice (see <a href="../Collaborations">collaboration</a>). EGF suppressed the reduction of colon length and rescued weight loss phenotype. </div>
                    <div class="p">(B) We have constructed a therapeutic biofilm system (in principle) for potential delivery of therapeutic molecules, in which we successfully fused a demo protein (EGF) to the biofilm protein CsgA in CsgA null bacteria (see <a href="../Project#Therapeutic_Biofilm">therapeutic biofilm</a>). The demo protein can be easily replaced by other therapeutic molecules which can function remotely (such as enzymes) without detaching from the biofilm, and thereby helping patients in long term. This is illustrated in Figure 2.</div>
                    <div class="row">
                        <div class="col-md-12">
                            <img class="img-responsive" style="margin:30px auto;" src="../img/proof2.png">
                        </div>
                        <div style="font-size:16px;text-align:center;width:80%;display:block;margin:10%;margin-bottom:1em;">
                            <b>Figure 2.</b>
                        </div>
                    </div>
                    <div class="p">(C). We have constructed a “warship” to protect and confine our engineered bacteria, attempting to increase the surviving power of introduced bacteria against native microbiota and biosafety levels of using engineered bacteria, but still allow exchanging of nutrient and chemical through semi-permeable membranes (see <a href="../Project#Warship">warship</a>). This is illustrated in Figure 3.</div>
                    <div class="row">
                        <div class="col-md-6">
                            <img class="img-responsive" style="height:300px;margin:30px auto;" src="../img/proof3.jpg">
                        </div>
                        <div class="col-md-6">
                            <img class="img-responsive" style="height:300px;margin:30px auto;" src="../img/proof4.png">
                        </div>
                        <div style="font-size:16px;text-align:center;width:80%;display:block;margin:10%;margin-bottom:1em;">
                            <b>Figure 3.</b>
                        </div>
                    </div>
                    <div class="p">(D). We have constructed two kill switches which can inhibit bacteria growth under our control (see <a href="../Project#Kill_Switch">kill switch</a>). We can either use light (via toxin fluorescent protein <a href="../Project#Kill_Switch">killer red</a>) or a small molecule (via cell lysis protein <a href="../Project#Kill_Switch">gene E</a>) to switch on the kill switch to terminate them when necessary. This is illustrated in Figure 4.</div>
                    <div class="row">
                        <div class="col-md-12">
                            <img class="img-responsive" style="margin:30px auto;" src="../img/proof5.png">
                        </div>
                        <div style="font-size:16px;text-align:center;width:80%;display:block;margin:10%;margin-bottom:1em;">
                            <b>Figure 4.</b>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

	<script src="../js/footer.js"></script>
</body>
</html>